Top Markets
Coin of the day
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Rank in Stocks #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Share Price
$20.65
Last synced: 2023-03-01
Market Cap
$82.52M
Change (1 day)
-0.58%
Change (1 year)
0.00%
Country
US
Trade Opiant Pharmaceuticals, Inc. (OPNT)

Category

EPS for Opiant Pharmaceuticals, Inc. (OPNT)
EPS as of 2026 TTM: 0
According to Opiant Pharmaceuticals, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Opiant Pharmaceuticals, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH